Breaking News Instant updates and real-time market news.

PGNX

Progenics

$5.36

0.165 (3.18%)

04:55
11/27/18
11/27
04:55
11/27/18
04:55

Progenics management to meet with Needham

Meeting to be held in Southern California on November 27 hosted by Needham.

  • 27

    Nov

PGNX Progenics
$5.36

0.165 (3.18%)

03/23/18
NEED
03/23/18
NO CHANGE
Target $14
NEED
Strong Buy
Needham still confident in Progenics approval despite PDUFA delay
The three month extension to Progenics' FDA action date is not related to the efficacy or safety data for Azdera, Needham analyst Chad Messer tells investors in a research note. The analyst remains confident in the drug's approval. He maintains a Strong Buy rating on the shares with a $14 price target.
07/31/18
NEED
07/31/18
NO CHANGE
Target $16
NEED
Strong Buy
Progenics price target raised to $16 from $14 at Needham
Needham analyst Chad Messer raised his price target on Progenics to $16 after the FDA approved Azedra for intravenous use for certain types of locally advanced or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy. Messer keeps a Strong Buy rating on Progenics shares.
09/13/18
NEED
09/13/18
DOWNGRADE
NEED
Buy
Progenics downgraded to Buy from Strong Buy at Needham
09/13/18
09/13/18
DOWNGRADE
Target $12

Buy
Progenics downgraded to Buy on Phase III trial disappointment at Needham
As previously reported, Needham analyst Chad Messer downgraded Progenics to Buy from Strong Buy after its Phase III study of PSMA imaging agent 1404 in prostate cancer missed its co-primary sensitivity endpoint. Although the study did meet the specificity endpoint, the analyst believes these results fall short of expectations set based on strong Phase II results. Additionally, Messer notes that the limitations of 1404 are likely due to the SPECT/CT platform and sees no read through to PyL, Progenic's other PSMA based imaging agent that works on the more sensitive PET imaging platform. The analyst also lowered his price target on the shares to $12 from $16.

TODAY'S FREE FLY STORIES

NUS

Nu Skin

$49.35

(0.00%)

09:47
03/25/19
03/25
09:47
03/25/19
09:47
Hot Stocks
Nu Skin falls -4.8% »

Nu Skin is down -4.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEL

Cellcom Israel

$3.76

(0.00%)

09:47
03/25/19
03/25
09:47
03/25/19
09:47
Hot Stocks
Cellcom Israel falls -5.1% »

Cellcom Israel is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCM

Cheetah Mobile

$6.25

-0.69 (-9.94%)

09:47
03/25/19
03/25
09:47
03/25/19
09:47
Hot Stocks
Cheetah Mobile falls -7.7% »

Cheetah Mobile is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

TCI

Transcontinental Realty Inc

$31.23

-6.48 (-17.18%)

09:47
03/25/19
03/25
09:47
03/25/19
09:47
Hot Stocks
Transcontinental Realty Inc rises 5.0% »

Transcontinental Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIER

Tier REIT

$27.74

2.23 (8.74%)

09:47
03/25/19
03/25
09:47
03/25/19
09:47
Hot Stocks
Tier REIT rises 8.4% »

Tier REIT is up 8.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

AVYA

Avaya

$17.74

4.51 (34.09%)

09:47
03/25/19
03/25
09:47
03/25/19
09:47
Hot Stocks
Avaya rises 34.1% »

Avaya is up 34.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$142.50

-1.34 (-0.93%)

09:46
03/25/19
03/25
09:46
03/25/19
09:46
Recommendations
Lululemon analyst commentary  »

MKM lowers Lululemon Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

AGCO

Agco

$67.65

0.27 (0.40%)

09:45
03/25/19
03/25
09:45
03/25/19
09:45
Recommendations
Agco analyst commentary  »

Agco price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

D

Dominion

$75.51

(0.00%)

09:44
03/25/19
03/25
09:44
03/25/19
09:44
Conference/Events
Dominion to host investor day »

Sustainability and ESG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 25

    Mar

  • 07

    May

BOXL

Boxlight

$2.76

(0.00%)

09:43
03/25/19
03/25
09:43
03/25/19
09:43
Hot Stocks
Boxlight receives $4M investment from The Lind Partners »

Boxlight Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

D

Dominion

$75.51

(0.00%)

09:41
03/25/19
03/25
09:41
03/25/19
09:41
Conference/Events
Dominion to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 25

    Mar

  • 07

    May

INTC

Intel

$53.20

(0.00%)

, AMD

AMD

$26.43

(0.00%)

09:40
03/25/19
03/25
09:40
03/25/19
09:40
Recommendations
Intel, AMD analyst commentary  »

CPU channel sell through…

INTC

Intel

$53.20

(0.00%)

AMD

AMD

$26.43

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 25

    Apr

VIAB

Viacom

$25.27

(0.00%)

, IYR

DJ US Real Estate Index Fund

$85.88

(0.00%)

09:40
03/25/19
03/25
09:40
03/25/19
09:40
Options
Unusually active option classes on open March 25th »

Unusual total active…

VIAB

Viacom

$25.27

(0.00%)

IYR

DJ US Real Estate Index Fund

$85.88

(0.00%)

NOK

Nokia

$5.94

(0.00%)

XLV

Health Care Select Sector SPDR

$90.70

(0.00%)

SQQQ

ProShares UltraPro Short QQQ

$10.36

(0.00%)

CRON

Cronos Group

$19.45

(0.00%)

XLU

Utilities SPDR

$58.60

(0.00%)

AAPL

Apple

$191.11

(0.00%)

JPM

JPMorgan

$99.78

(0.00%)

EWZ

MSCI Brazil Index

$40.34

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

  • 12

    Apr

  • 20

    May

ADI

Analog Devices

$107.34

-2.79 (-2.53%)

09:38
03/25/19
03/25
09:38
03/25/19
09:38
Downgrade
Analog Devices rating change  »

Analog Devices downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Apr

  • 28

    May

TLND

Talend

$49.40

-1.81 (-3.53%)

09:36
03/25/19
03/25
09:36
03/25/19
09:36
Recommendations
Talend analyst commentary  »

Talend price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHI

Robert Half

$63.78

-2.58 (-3.89%)

09:36
03/25/19
03/25
09:36
03/25/19
09:36
Hot Stocks
Breaking Hot Stocks news story on Robert Half »

Robert Half mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$109.51

-2.68 (-2.39%)

09:35
03/25/19
03/25
09:35
03/25/19
09:35
Downgrade
Texas Instruments rating change  »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

LNTH

Lantheus

$23.61

-1.575 (-6.25%)

09:33
03/25/19
03/25
09:33
03/25/19
09:33
Hot Stocks
Lantheus promotes John Bolla to COO »

Lantheus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

MEOH

Methanex

$57.73

-2.64 (-4.37%)

09:33
03/25/19
03/25
09:33
03/25/19
09:33
Hot Stocks
M&G Investments announces four director nominees for Methanex board »

M&G Investments, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$41.28

0.75 (1.85%)

09:32
03/25/19
03/25
09:32
03/25/19
09:32
Recommendations
D.R. Horton analyst commentary  »

D.R. Horton benefiting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

LNTH

Lantheus

$23.61

-1.575 (-6.25%)

09:31
03/25/19
03/25
09:31
03/25/19
09:31
Hot Stocks
Lantheus announces upcoming retirement of Chief Medical Officer in September »

Lantheus Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

NEON

Neonode

$2.80

(0.00%)

09:28
03/25/19
03/25
09:28
03/25/19
09:28
Hot Stocks
Neonode says Convergence Promotions to act as sales and marketing partner »

Neonode announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLXP

PLx Pharma

$5.54

-0.525 (-8.66%)

09:27
03/25/19
03/25
09:27
03/25/19
09:27
Syndicate
Breaking Syndicate news story on PLx Pharma »

PLx Pharma files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$184.59

-6.555 (-3.43%)

09:26
03/25/19
03/25
09:26
03/25/19
09:26
Hot Stocks
Wex to acquire fuel card business of EG Group »

WEX announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IART

Integra LifeSciences

$55.29

-2.07 (-3.61%)

09:25
03/25/19
03/25
09:25
03/25/19
09:25
Conference/Events
Integra LifeSciences participates in a conference call with JPMorgan »

Medical Supplies &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.